Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Non-small Cell Lung Cancer Metastatic 1

Interventions

Cyclophosphamide 416 Radiotherapy 276 fludarabine 238 Gemcitabine 211 Cisplatin 203 Nivolumab 184 pembrolizumab 183 Paclitaxel 176 Carboplatin 168 Magnetic Resonance Spectroscopy 167 fludarabine phosphate 156 Irinotecan 135 Bevacizumab 133 Cytarabine 128 Specimen Handling 125 Capecitabine 124 Temozolomide 123 Radiosurgery 118 Biopsy 117 Docetaxel 116 Dexamethasone 113 Ipilimumab 112 Radiation 111 Oxaliplatin 110 Fluorouracil 110 Rituximab 108 Etoposide 108 Filgrastim 99 Lenalidomide 98 Everolimus 96

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER × GC Temporary Stopping × Clear all

NCT06127940 2023-11-13

K-SAB

Karolinska University Hospital

Phase 1 Unknown

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡